Despite some similar signaling pathways, NOD1 and NOD2 can produce divergent metabolic and immunometabolism outcomes, including regulation of blood glucose and adipose tissue inflammation during obesity.20 This evidence concerns the gene NOD2 and obesity due to melanocortin 4 receptor deficiency.